X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (379) 379
Newspaper Article (76) 76
Publication (47) 47
Patent (10) 10
Dissertation (2) 2
Book Chapter (1) 1
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (156) 156
humans (144) 144
oncology (118) 118
male (77) 77
middle aged (65) 65
female (61) 61
cancer (59) 59
carcinoma, renal cell - drug therapy (55) 55
kidney neoplasms - drug therapy (52) 52
aged (51) 51
sunitinib (48) 48
metastasis (47) 47
animals (46) 46
life sciences (44) 44
urology & nephrology (43) 43
kidney neoplasms - pathology (41) 41
renal cell carcinoma (41) 41
adult (38) 38
carcinoma, renal cell (37) 37
survival (37) 37
hematology, oncology and palliative medicine (34) 34
treatment outcome (33) 33
antineoplastic agents - therapeutic use (31) 31
interferon-alpha (31) 31
analysis (30) 30
care and treatment (30) 30
disease-free survival (30) 30
sorafenib (30) 30
mice (29) 29
carcinoma, renal cell - pathology (28) 28
everolimus (28) 28
prognosis (28) 28
targeted therapy (27) 27
neoplasm metastasis (26) 26
urology (26) 26
article (23) 23
cell biology (23) 23
chemotherapy (23) 23
prostate cancer (23) 23
therapy (23) 23
tumors (23) 23
aged, 80 and over (22) 22
cellular biology (22) 22
carcinoma, renal cell - secondary (20) 20
retrospective studies (20) 20
trial (19) 19
kidney cancer (18) 18
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
governors (17) 17
immunotherapy (17) 17
risk factors (17) 17
vascular endothelial growth factor (17) 17
cell adhesion (16) 16
kaplan-meier estimate (16) 16
carcinoma (15) 15
diagnosis (15) 15
efficacy (15) 15
molecular targeted therapy (15) 15
carcinoma, renal cell - genetics (14) 14
clinical trials (14) 14
extracellular matrix - metabolism (14) 14
integrins (14) 14
kidney neoplasms - genetics (14) 14
nivolumab (14) 14
open-label (14) 14
young adult (14) 14
angiogenesis (13) 13
bevacizumab (13) 13
cell line (13) 13
double-blind (13) 13
expression (13) 13
integrin (13) 13
kidney neoplasms - metabolism (13) 13
metastases (13) 13
metastatic renal cell carcinoma (13) 13
protein binding (13) 13
protein kinase inhibitors - therapeutic use (13) 13
actin (12) 12
antimitotic agents (12) 12
antineoplastic agents (12) 12
carcinoma, renal cell - metabolism (12) 12
nephrectomy (12) 12
signal transduction (12) 12
survival analysis (12) 12
[ sdv.bc ] life sciences [q-bio]/cellular biology (11) 11
adhesion (11) 11
apoptosis (11) 11
axitinib (11) 11
clear cell-type renal cell carcinoma (11) 11
health aspects (11) 11
integrin beta1 - metabolism (11) 11
management (11) 11
medical research (11) 11
neoplasm staging (11) 11
patients (11) 11
antineoplastic agents - adverse effects (10) 10
carcinoma, renal cell - mortality (10) 10
classification (10) 10
focal adhesions (10) 10
kidney neoplasms - mortality (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Linehan, W. Marston and Spellman, Paul T and Ricketts, Christopher J and Creighton, Chad J and Fei, Suzanne S and Davis, Caleb and Wheeler, David A and Murray, Bradley A and Schmidt, Laura and Vocke, Cathy D and Peto, Myron and Al Mamun, Abu Amar M and Shinbrot, Eve and Sethi, Anurag and Brooks, Samira and Rathmell, W. Kimryn and Brooks, Angela N and Hoadley, Katherine A and Robertson, A. Gordon and Brooks, Denise and Bowlby, Reanne and Sadeghi, Sara and Shen, Hui and Weisenberger, Daniel J and Bootwalla, Moiz and Baylin, Stephen B and Laird, Peter W and Cherniack, Andrew D and Saksena, Gordon and Haake, Scott and Li, Jun and Liang, Han and Lu, Yiling and Mills, Gordon B and Akbani, Rehan and Leiserson, Mark D.M and Raphael, Benjamin J and Anur, Pavana and Bottaro, Donald and Albiges, Laurence and Barnabas, Nandita and Choueiri, Toni K and Czerniak, Bogdan and Godwin, Andrew K and Hakimi, A. Ari and Ho, Thai H and Hsieh, James and Ittmann, Michael and Kim, William Y and Krishnan, Bhavani and Merino, Maria J and Shaw, Kenna R. Mills and Reuter, Victor E and Reznik, Ed and Shelley, Carl S and Shuch, Brian and Signoretti, Sabina and Srinivasan, Ramaprasad and Tamboli, Pheroze and Thomas, George and Tickoo, Satish and Burnett, Kenneth and Crain, Daniel and Gardner, Johanna and Lau, Kevin and Mallery, David and Morris, Scott and Paulauskis, Joseph D and Penny, Robert J and Shelton, Candace and Shelton, W. Troy and Sherman, Mark and Thompson, Eric and Yena, Peggy and Avedon, Melissa T and Bowen, Jay and Gastier-Foster, Julie M and Gerken, Mark and Leraas, Kristen M and Lichtenberg, Tara M and Ramirez, Nilsa C and Santos, Tracie and Wise, Lisa and Zmuda, Erik and Demchok, John A and Felau, Ina and Hutter, Carolyn M and Sheth, Margi and Sofia, Heidi J and Tarnuzzer, Roy and Wang, Zhining and Yang, Liming and Zenklusen, Jean C and Zhang, Jiashan and Ayala, Brenda and Baboud, Julien and Chudamani, Sudha and Liu, Jia and Lolla, Laxmi and Naresh, Rashi and ... and The Cancer Genome Atlas Research Network and Canc Genome Atlas Res Network and Cancer Genome Atlas Research Network
The New England Journal of Medicine, ISSN 0028-4793, 01/2016, Volume 374, Issue 2, pp. 135 - 145
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2018, Volume 29, Issue suppl_8
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. 243 - 256
Journal Article
Science, ISSN 0036-8075, 01/2018, Volume 359, Issue 6371, pp. 91 - 97
Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis induce sustained clinical responses in a sizable minority of cancer patients. We found that... 
CELL LUNG-CANCER | MELANOMA | MICROENVIRONMENT | INTESTINAL MICROBIOTA | CYCLOPHOSPHAMIDE | PD-1 BLOCKADE | MULTIDISCIPLINARY SCIENCES | GENES | RESISTANCE | ANTITUMOR IMMUNITY | NIVOLUMAB | CD4 Antigens - immunology | Immunotherapy - methods | Humans | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Gastrointestinal Microbiome - genetics | Fecal Microbiota Transplantation | Anti-Bacterial Agents - therapeutic use | Feces - microbiology | Metagenome - genetics | Neoplasms - therapy | Animals | Receptors, CCR - immunology | Interleukin-12 - immunology | Receptors, CXCR3 - immunology | T-Lymphocytes - immunology | Mice | Gastrointestinal Microbiome - immunology | Verrucomicrobia - genetics | Verrucomicrobia - immunology | Care and treatment | Cell receptors | Microbiota (Symbiotic organisms) | Immunotherapy | Epithelial tumors | Physiological aspects | Health aspects | Methods | Apoptosis | PD-1 protein | Interleukin | Microbiomes | Transplantation | Lymphocytes T | Anticancer properties | Microbiota | Lymphocytes | Bacteria | Feces | Supplementation | Gnotobiotics | Kidneys | Melanoma | Dietary supplements | Interleukin 12 | Abundance | CXCR3 protein | Patients | CD4 antigen | Immune checkpoint | Antibiotics | Lungs | Flora | PD-L1 protein | Relative abundance | Antitumor activity | CCR9 protein | Tumors | Kidney transplantation | Cancer | Life Sciences
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 69, pp. 151 - 157
Journal Article
European Journal of Cancer, ISSN 0959-8049, 12/2016, Volume 69, p. 151
Background: Patients with germ cell tumours (GCT) receiving cisplatin-based chemotherapy are at high risk of thromboembolic events (TEE). Previously, we... 
Anticoagulants | Dehydrogenases | Prophylaxis | Lactate dehydrogenase | Risk analysis | Thrombosis | Patients | Cisplatin | L-Lactate dehydrogenase | Risk factors | Chemotherapy | Platinum | Lactic acid | Heparin | Thromboembolism | Surface area | Tumors
Journal Article
European Journal of Cancer, ISSN 0959-8049, 12/2016, Volume 69, p. 151
Abstract Background: Patients with germ cell tumours (GCT) receiving cisplatin-based chemotherapy are at high risk of thromboembolic events (TEE). Previously,... 
Anticoagulants | Medical treatment | Prophylaxis | Lactate dehydrogenase | Thrombophlebitis | Risk analysis | Patients | Thrombosis | Cisplatin | L-Lactate dehydrogenase | Molecular chains | Risk factors | Studies | Chemotherapy | Lactic acid | Heparin | Thromboembolism | Surface area | Tumors
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2018, Volume 379, Issue 5, pp. 417 - 427
Journal Article
by Gravis, G and Fizazi, K and Joly Lobbedez, F and Oudard, S and Priou, F and Latorzeff, I and Delva, R and Krakowski, I and Laguerre, B and Rolland, F and Theodore, C and Deplanque, G and Ferrero, J. M and Pouessel, D and Mourey, L and Beuzeboc, P and Zanetta, S and Esterni, B and Habibian, M and Soulie, M and Ryan, C. J and Morris, M and Molina, A and Piulats, J. R and De Souza, P and Li, J and Kheoh, T and de Bono, J. S and Larson, S and Griffin, T and Matheny, S and Naini, V and Scher, H. I and Small, E and Basch, E and Logothetis, C. J and Rathkopf, D. E and Smith, M. R and Mainwaring, P. N and Hao, Y and Li, S and Meyers, M and Cleeland, C and Saad, F and Sternberg, C. N and Miller, K and Mulders, P and Chi, K and Hirmand, M and Rathkopf, D and Corn, P. G and Mukherji, D and Harzstark, A. L and Sartor, O. A and Smith, D. C and Tunariu, N and Sweeney, C and Parker, C and Coleman, R. E and Nilsson, S and Vogelzang, N and Lloyd, A. J and Staudacher, K and van Gool, R and Sartor, A. O and Taplin, M and Armstrong, A. J and Selby, B and Yu, E. Y and Ellard, S and Hotte, S. J and Gingerich, J. R and Joshua, A. M and Gleave, M. E and Sonpavde, G and Pond, G. R and Galsky, M. D and Wood, B. A and Wang, S and Paolini, J and Lechuga, M and Michaelson, M. D and Liede, A and Gunther, O and Bennett, B and Wong, S and Pezaro, C and Omlin, A. G and Sandhu, S and Bianchini, D and Cassidy, A. M and Maier, G and Olmos, D and Attard, G and Dixit, S and Tito, J and Afzal, P and Wolff, J. M and Gedamke, M and Li, C and ...
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ix294 - ix318
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2019, Volume 380, Issue 12, pp. 1103 - 1115
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2016, Volume 22, Issue 22, pp. 5461 - 5471
Journal Article
by Ravaud, A and Barrios, C and Anak, O and Pelov, D and Louveau, A and Alekseev, B and M-H, T and Agarwala, S. S and Yalcin, S and Melichar, B and McDermott, D. F and Drake, C. G and Sznol, M and Choueiri, T. K and Powderly, J. D and Smith, D. C and Wigginton, J. M and Kollia, G and Gupta, A and Atkins, M. B and Donskov, F and Michaelson, M. D and Puzanov, I and Davis, M. P and Bjarnason, G. A and Motzer, R. J and Lin, X and Cohen, D. P and Wiltshire, R and Rini, B. I and Oudard, S and Culine, S and Vieillefond, A and Priou, F and Goldwasser, F and Gravis-Mescam, G and Deplanque, G and Machiels, J. P and Beuzeboc, P and Sonpavde, G and Maughan, B and Boucher, K. M and Fougeray, R and Niegisch, G and Wong, Y and Sridhar, S. S and Sternberg, C. N and Bellmunt, J and Booth, C. M and Siemens, D. R and Li, G and Peng, Y and Tannock, I. F and Berman, D. M and Kong, W and Mackillop, W. J and Selle, F and Fizazi, K and Biron, P and Bui, B and Bay, J and Flechon, A and Dubot, C and Caty, A and Burcoveanu, D and Delva, R and de Revel, T and Miclea, J. M and Gaulet, M and Horn, E and Provent, S and Temby, I and Brindel, I and Khalil, J and Gligorov, J and Lotz, J.- P and Quinn, D. I and Hamid, O and Tsao-Wei, D and Hu, J and Pinski, J and Schuckman, A and Daneshmand, S and Groshen, S and Raghavan, D and Korn, C and Massopust, K and Ketchens, C and Aparicio, A. M and Dorff, T. B and Zurita-Saavedra, A and Liu, Y and Lin, Y and Tran, H. T and Pandite, L. N and Heymach, J. V and Cella, D and Kaiser, K and Beaumont, J and Diaz, J and ... and VEG105192 Team and investigators
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ix258 - ix293
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2017, Volume 28, Issue suppl_5
Journal Article